These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1344442)

  • 41. [13II therapy of metastatic carcinoma of thyroid (author's transl)].
    Ma J
    Zhonghua Fang She Xue Za Zhi; 1979; 13(4):228-32. PubMed ID: 162412
    [No Abstract]   [Full Text] [Related]  

  • 42. [Management of iodine-131 ablation therapy for thyroid carcinoma in a patient on chronic hemodialysis].
    Zenasni N; Elkhayat S; Taleb S; Zamd M; Medkouri G; Benghanem Gharbi M; Ramdani B; Aschawa H; Guensi A
    Nephrol Ther; 2015 Apr; 11(2):114-7. PubMed ID: 25709102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiation dose rate and urinary activity in patients with differentiated thyroid carcinoma treated with radioiodine-131; a survey in Iranian population.
    Shahhosseini S; Beiki D; Dadashzadeh S; Eftekhari M; Tayebi H; Moosazadeh Rashti G
    Hell J Nucl Med; 2004; 7(3):192-4. PubMed ID: 15841298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The real cost of theoretic risk avoidance: the need to challenge unsubstantiated concerns about (131)I therapy.
    Goldsmith SJ
    J Nucl Med; 2011 May; 52(5):681-2. PubMed ID: 21498535
    [No Abstract]   [Full Text] [Related]  

  • 45. Radiation dose rates of differentiated thyroid cancer patients after
    Jin P; Feng H; Ouyang W; Wu J; Chen P; Wang J; Sun Y; Xian J; Huang L
    Radiat Environ Biophys; 2018 May; 57(2):169-177. PubMed ID: 29525896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The usual dose of I-13U used to ablate thyroid.
    Caplan RH; Dvorak D
    J Nucl Med; 1977 Sep; 18(9):946. PubMed ID: 893800
    [No Abstract]   [Full Text] [Related]  

  • 47. Commentary on Willegaignon et al.: outpatient radioiodine therapy for thyroid cancer: a safe nuclear medicine procedure.
    Marcus CS
    Clin Nucl Med; 2011 Jun; 36(6):446. PubMed ID: 21552021
    [No Abstract]   [Full Text] [Related]  

  • 48. [Radiotherapy of struma maligna].
    Engelken G; Hymmen U; Schenck P; Wieland C
    Chirurg; 1976 Aug; 47(8):435-8. PubMed ID: 821730
    [No Abstract]   [Full Text] [Related]  

  • 49. EVALUATION OF THE RELEASE CRITERIA FROM HOSPITAL OF THYROID CARCINOMA PATIENT TREATED WITH 131I.
    Lahfi Y; Anjak O
    Radiat Prot Dosimetry; 2016 Dec; 171(4):534-538. PubMed ID: 26590393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selected Radiation Safety Aspects Including Transportation and Lodging After Outpatient
    Gomes-Lima CJ; Wu D; Kharazi PH; Khojekar GJ; Ringel MD; Vetter RJ; Bloom G; Burman KD; Wartofsky L; Van Nostrand D
    Thyroid; 2017 Dec; 27(12):1558-1565. PubMed ID: 29132255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic myeloid leukaemia following radioiodine therapy for carcinoma thyroid.
    Bundi RS; Scott JS; Halnan KE
    Br J Radiol; 1977 Jan; 50(589):61-4. PubMed ID: 264404
    [No Abstract]   [Full Text] [Related]  

  • 52. Oedema of the neck after ablation of the thyroid with radioactive iodine.
    Goolden AW; Kam KC; Fitzpatrick ML; Munro AJ
    Br J Radiol; 1986 Jun; 59(702):583-6. PubMed ID: 3708267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A proposal to improve radioactive waste disposal following metabolic radio-iodine therapy].
    Bekier A
    Strahlentherapie; 1975 May; 149(5):499-503. PubMed ID: 1154447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiation safety in the management of patients undergoing radioactive iodine ablation therapy.
    Beck M
    Clin J Oncol Nurs; 2015 Feb; 19(1):44-6. PubMed ID: 25689648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment.
    Kloos RT
    Thyroid; 2009 Sep; 19(9):925-8. PubMed ID: 19731974
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pregnancy after treatment with 131 radioiodine in women with differentiated thyroid carcinoma].
    Matsumura LK
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):507-8. PubMed ID: 17684608
    [No Abstract]   [Full Text] [Related]  

  • 57. Reproducibility of radioactive iodine uptake (RAIU) measurements.
    Pelletier-Galarneau M; Martineau P; Klein R; Henderson M; Zuckier LS
    J Appl Clin Med Phys; 2018 Jan; 19(1):239-242. PubMed ID: 29165912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conception after iodine-131 therapy for differentiated thyroid cancer.
    Ayala C; Navarro E; Rodríguez JR; Silva H; Venegas E; Astorga R
    Thyroid; 1998 Nov; 8(11):1009-11. PubMed ID: 9848714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management and autopsy of a radioactive cadaver.
    Wallace AB; Bush V
    Australas Phys Eng Sci Med; 1991 Jun; 14(2):119-24. PubMed ID: 1747080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer.
    Izembart M; Chavaudra J; Aubert B; Vallée G
    Eur J Nucl Med; 1992; 19(4):243-7. PubMed ID: 1597239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.